Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOpen Orphan Media (ORPH)

Share Price Information for Open Orphan (ORPH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 16.00
Bid: 16.10
Ask: 16.50
Change: 0.00 (0.00%)
Spread: 0.40 (2.48%)
Open: 14.30
High: 16.00
Low: 15.15
Yest. Close: 14.25
ORPH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Latest Open Orphan Media

05:07

What's Hot 16-20 March #ORPH #MRW #TSCO #NXT #IHC #NCYT #GYM #HWSL

Which stock has alleviated a little stock market despair, will Gym Group overthrow threats of social isolation, will Next revise its profit guidance, can Hadrians Wall morph into a new business, and a...

15:46

Cathal Friel refocuses Open Orphan as he raises 5m and buys virology specialist hVivo

In a wide-ranging interview with London South East, Open Orphan Executive Chairman Cathal Friel outlines his vision for the business and explains how the combined talents of Open Orphan, hVivo and Ven...

23:59

Pharma Services company Open Orphan presenting at Hardman's November Forum

Welcome to the November Hardman & Co Investor Forum. Hardman had the usual four companies presenting, filmed by London South East on behalf of Hardman. Open Orphan #ORPH was founded in 2017, with...

1:54:36

Hardman Investor Forum: Primary Health Properties, Open Orphan, Surface Transforms, NSF

Welcome to the November Hardman & Co Investor Forum. Hardman had the usual four companies presenting, and this is the webcast of the evening, filmed by London South East on behalf of Hardman. In o...

30:44

Cathal Friel, CEO, Open Orphan, #ORPH at the London South East Life Sciences Investor Briefing

This webcast shows Cathal Friel, the CEO of Open Orphan #ORPH giving his presentation at our Life Sciences Investor Briefing in the City of London and includes the Q&A. Open Orphan is building a ...

04:54

What's Hot for #UJO, #ESL, #RENE, #GYM, #TRAF, #SDRY, #ORPH

Which company provides free facial expressions, what's the hysteria surrounding Union Jack Oil, why the long faces at Trafalgar Property and which Chief Financial Officers are making a difference at t...

14:14

Cathal Friel, CEO of pharma services company #OpenOrphan explains the investment opportunity

#ORPH. Cathal Friel, Open Orphan CEO explains how he plans to buy and build a pharma services company. He believes the pharma rare orphan asset space is the hot spot at the moment, and providing servi...

1:54:36

Hardman Investor Forum: Primary Health Properties, Open Orphan, Surface Transforms, NSF

Welcome to the November Hardman & Co Investor Forum. Hardman had the usual four companies presenting, and this is the webcast of the evening, filmed by London South East on behalf of Hardman. In o...

30:44

Cathal Friel, CEO, Open Orphan, #ORPH at the London South East Life Sciences Investor Briefing

This webcast shows Cathal Friel, the CEO of Open Orphan #ORPH giving his presentation at our Life Sciences Investor Briefing in the City of London and includes the Q&A. Open Orphan is building a ...

04:54

What's Hot for #UJO, #ESL, #RENE, #GYM, #TRAF, #SDRY, #ORPH

Which company provides free facial expressions, what's the hysteria surrounding Union Jack Oil, why the long faces at Trafalgar Property and which Chief Financial Officers are making a difference at t...

14:14

Cathal Friel, CEO of pharma services company #OpenOrphan explains the investment opportunity

#ORPH. Cathal Friel, Open Orphan CEO explains how he plans to buy and build a pharma services company. He believes the pharma rare orphan asset space is the hot spot at the moment, and providing servi...

1:54:36

Hardman Investor Forum: Primary Health Properties, Open Orphan, Surface Transforms, NSF

Welcome to the November Hardman & Co Investor Forum. Hardman had the usual four companies presenting, and this is the webcast of the evening, filmed by London South East on behalf of Hardman. In o...

30:44

Cathal Friel, CEO, Open Orphan, #ORPH at the London South East Life Sciences Investor Briefing

This webcast shows Cathal Friel, the CEO of Open Orphan #ORPH giving his presentation at our Life Sciences Investor Briefing in the City of London and includes the Q&A. Open Orphan is building a ...

04:54

What's Hot for #UJO, #ESL, #RENE, #GYM, #TRAF, #SDRY, #ORPH

Which company provides free facial expressions, what's the hysteria surrounding Union Jack Oil, why the long faces at Trafalgar Property and which Chief Financial Officers are making a difference at t...

14:14

Cathal Friel, CEO of pharma services company #OpenOrphan explains the investment opportunity

#ORPH. Cathal Friel, Open Orphan CEO explains how he plans to buy and build a pharma services company. He believes the pharma rare orphan asset space is the hot spot at the moment, and providing servi...

1:54:36

Hardman Investor Forum: Primary Health Properties, Open Orphan, Surface Transforms, NSF

Welcome to the November Hardman & Co Investor Forum. Hardman had the usual four companies presenting, and this is the webcast of the evening, filmed by London South East on behalf of Hardman. In o...

30:44

Cathal Friel, CEO, Open Orphan, #ORPH at the London South East Life Sciences Investor Briefing

This webcast shows Cathal Friel, the CEO of Open Orphan #ORPH giving his presentation at our Life Sciences Investor Briefing in the City of London and includes the Q&A. Open Orphan is building a ...

04:54

What's Hot for #UJO, #ESL, #RENE, #GYM, #TRAF, #SDRY, #ORPH

Which company provides free facial expressions, what's the hysteria surrounding Union Jack Oil, why the long faces at Trafalgar Property and which Chief Financial Officers are making a difference at t...

14:14

Cathal Friel, CEO of pharma services company #OpenOrphan explains the investment opportunity

#ORPH. Cathal Friel, Open Orphan CEO explains how he plans to buy and build a pharma services company. He believes the pharma rare orphan asset space is the hot spot at the moment, and providing servi...

1:54:36

Hardman Investor Forum: Primary Health Properties, Open Orphan, Surface Transforms, NSF

Welcome to the November Hardman & Co Investor Forum. Hardman had the usual four companies presenting, and this is the webcast of the evening, filmed by London South East on behalf of Hardman. In o...

30:44

Cathal Friel, CEO, Open Orphan, #ORPH at the London South East Life Sciences Investor Briefing

This webcast shows Cathal Friel, the CEO of Open Orphan #ORPH giving his presentation at our Life Sciences Investor Briefing in the City of London and includes the Q&A. Open Orphan is building a ...

04:54

What's Hot for #UJO, #ESL, #RENE, #GYM, #TRAF, #SDRY, #ORPH

Which company provides free facial expressions, what's the hysteria surrounding Union Jack Oil, why the long faces at Trafalgar Property and which Chief Financial Officers are making a difference at t...

14:14

Cathal Friel, CEO of pharma services company #OpenOrphan explains the investment opportunity

#ORPH. Cathal Friel, Open Orphan CEO explains how he plans to buy and build a pharma services company. He believes the pharma rare orphan asset space is the hot spot at the moment, and providing servi...

1:54:36

Hardman Investor Forum: Primary Health Properties, Open Orphan, Surface Transforms, NSF

Welcome to the November Hardman & Co Investor Forum. Hardman had the usual four companies presenting, and this is the webcast of the evening, filmed by London South East on behalf of Hardman. In o...

30:44

Cathal Friel, CEO, Open Orphan, #ORPH at the London South East Life Sciences Investor Briefing

This webcast shows Cathal Friel, the CEO of Open Orphan #ORPH giving his presentation at our Life Sciences Investor Briefing in the City of London and includes the Q&A. Open Orphan is building a ...

04:54

What's Hot for #UJO, #ESL, #RENE, #GYM, #TRAF, #SDRY, #ORPH

Which company provides free facial expressions, what's the hysteria surrounding Union Jack Oil, why the long faces at Trafalgar Property and which Chief Financial Officers are making a difference at t...

14:14

Cathal Friel, CEO of pharma services company #OpenOrphan explains the investment opportunity

#ORPH. Cathal Friel, Open Orphan CEO explains how he plans to buy and build a pharma services company. He believes the pharma rare orphan asset space is the hot spot at the moment, and providing servi...

1:54:36

Hardman Investor Forum: Primary Health Properties, Open Orphan, Surface Transforms, NSF

Welcome to the November Hardman & Co Investor Forum. Hardman had the usual four companies presenting, and this is the webcast of the evening, filmed by London South East on behalf of Hardman. In o...

30:44

Cathal Friel, CEO, Open Orphan, #ORPH at the London South East Life Sciences Investor Briefing

This webcast shows Cathal Friel, the CEO of Open Orphan #ORPH giving his presentation at our Life Sciences Investor Briefing in the City of London and includes the Q&A. Open Orphan is building a ...

04:54

What's Hot for #UJO, #ESL, #RENE, #GYM, #TRAF, #SDRY, #ORPH

Which company provides free facial expressions, what's the hysteria surrounding Union Jack Oil, why the long faces at Trafalgar Property and which Chief Financial Officers are making a difference at t...

14:14

Cathal Friel, CEO of pharma services company #OpenOrphan explains the investment opportunity

#ORPH. Cathal Friel, Open Orphan CEO explains how he plans to buy and build a pharma services company. He believes the pharma rare orphan asset space is the hot spot at the moment, and providing servi...

1:54:36

Hardman Investor Forum: Primary Health Properties, Open Orphan, Surface Transforms, NSF

Welcome to the November Hardman & Co Investor Forum. Hardman had the usual four companies presenting, and this is the webcast of the evening, filmed by London South East on behalf of Hardman. In o...

30:44

Cathal Friel, CEO, Open Orphan, #ORPH at the London South East Life Sciences Investor Briefing

This webcast shows Cathal Friel, the CEO of Open Orphan #ORPH giving his presentation at our Life Sciences Investor Briefing in the City of London and includes the Q&A. Open Orphan is building a ...

04:54

What's Hot for #UJO, #ESL, #RENE, #GYM, #TRAF, #SDRY, #ORPH

Which company provides free facial expressions, what's the hysteria surrounding Union Jack Oil, why the long faces at Trafalgar Property and which Chief Financial Officers are making a difference at t...

14:14

Cathal Friel, CEO of pharma services company #OpenOrphan explains the investment opportunity

#ORPH. Cathal Friel, Open Orphan CEO explains how he plans to buy and build a pharma services company. He believes the pharma rare orphan asset space is the hot spot at the moment, and providing servi...

1:54:36

Hardman Investor Forum: Primary Health Properties, Open Orphan, Surface Transforms, NSF

Welcome to the November Hardman & Co Investor Forum. Hardman had the usual four companies presenting, and this is the webcast of the evening, filmed by London South East on behalf of Hardman. In o...

30:44

Cathal Friel, CEO, Open Orphan, #ORPH at the London South East Life Sciences Investor Briefing

This webcast shows Cathal Friel, the CEO of Open Orphan #ORPH giving his presentation at our Life Sciences Investor Briefing in the City of London and includes the Q&A. Open Orphan is building a ...

04:54

What's Hot for #UJO, #ESL, #RENE, #GYM, #TRAF, #SDRY, #ORPH

Which company provides free facial expressions, what's the hysteria surrounding Union Jack Oil, why the long faces at Trafalgar Property and which Chief Financial Officers are making a difference at t...

14:14

Cathal Friel, CEO of pharma services company #OpenOrphan explains the investment opportunity

#ORPH. Cathal Friel, Open Orphan CEO explains how he plans to buy and build a pharma services company. He believes the pharma rare orphan asset space is the hot spot at the moment, and providing servi...

1:54:36

Hardman Investor Forum: Primary Health Properties, Open Orphan, Surface Transforms, NSF

Welcome to the November Hardman & Co Investor Forum. Hardman had the usual four companies presenting, and this is the webcast of the evening, filmed by London South East on behalf of Hardman. In o...

30:44

Cathal Friel, CEO, Open Orphan, #ORPH at the London South East Life Sciences Investor Briefing

This webcast shows Cathal Friel, the CEO of Open Orphan #ORPH giving his presentation at our Life Sciences Investor Briefing in the City of London and includes the Q&A. Open Orphan is building a ...

04:54

What's Hot for #UJO, #ESL, #RENE, #GYM, #TRAF, #SDRY, #ORPH

Which company provides free facial expressions, what's the hysteria surrounding Union Jack Oil, why the long faces at Trafalgar Property and which Chief Financial Officers are making a difference at t...

14:14

Cathal Friel, CEO of pharma services company #OpenOrphan explains the investment opportunity

#ORPH. Cathal Friel, Open Orphan CEO explains how he plans to buy and build a pharma services company. He believes the pharma rare orphan asset space is the hot spot at the moment, and providing servi...

1:54:36

Hardman Investor Forum: Primary Health Properties, Open Orphan, Surface Transforms, NSF

Welcome to the November Hardman & Co Investor Forum. Hardman had the usual four companies presenting, and this is the webcast of the evening, filmed by London South East on behalf of Hardman. In o...

30:44

Cathal Friel, CEO, Open Orphan, #ORPH at the London South East Life Sciences Investor Briefing

This webcast shows Cathal Friel, the CEO of Open Orphan #ORPH giving his presentation at our Life Sciences Investor Briefing in the City of London and includes the Q&A. Open Orphan is building a ...

04:54

What's Hot for #UJO, #ESL, #RENE, #GYM, #TRAF, #SDRY, #ORPH

Which company provides free facial expressions, what's the hysteria surrounding Union Jack Oil, why the long faces at Trafalgar Property and which Chief Financial Officers are making a difference at t...

14:14

Cathal Friel, CEO of pharma services company #OpenOrphan explains the investment opportunity

#ORPH. Cathal Friel, Open Orphan CEO explains how he plans to buy and build a pharma services company. He believes the pharma rare orphan asset space is the hot spot at the moment, and providing servi...

Login to your account

Don't have an account? Click here to register.